Selected research
Industry Research
Lidocaine Injection Industry Research Report 2026
Market perspective
The global Lidocaine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lidocaine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lidocaine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lidocaine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lidocaine Injection include Actiza Pharmaceutical, AdvaCare Pharma, Amphastar, AuroMedics, Hameln Pharmaceuticals, Hikma, Livealth Biopharma, Fresenius Kabi and Hainan Tianhuang Pharmacy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lidocaine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lidocaine Injection Market by Company
Actiza Pharmaceutical
AdvaCare Pharma
Amphastar
AuroMedics
Hameln Pharmaceuticals
Hikma
Livealth Biopharma
Fresenius Kabi
Hainan Tianhuang Pharmacy
Pfizer
JumpCan
LongerPharm Group
Yabao Pharmaceutical
Lidocaine Injection Segment by Type
0.02
0.015
0.01
0.005
Lidocaine Injection Segment by Application
Recovery Center
Hospital
Clinic
Lidocaine Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lidocaine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lidocaine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lidocaine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lidocaine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lidocaine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lidocaine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.02
- 0.015
- 0.01
- 0.005
Applications
- Recovery Center
- Hospital
- Clinic
Companies covered
- Actiza Pharmaceutical
- AdvaCare Pharma
- Amphastar
- AuroMedics
- Hameln Pharmaceuticals
- Hikma
- Livealth Biopharma
- Fresenius Kabi
- Hainan Tianhuang Pharmacy
- Pfizer
- JumpCan
- LongerPharm Group
- Yabao Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lidocaine Injection Market Size (2021-2032)
- 2.2.2 Global Lidocaine Injection Sales (2021-2032)
- 2.2.3 Global Lidocaine Injection Market Average Price (2021-2032)
- 2.3 Lidocaine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.02
- 2.3.3 0.015
- 2.3.4 0.01
- 2.3.5 0.005
- 2.4 Lidocaine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Recovery Center
- 2.4.3 Hospital
- 2.4.4 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lidocaine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lidocaine Injection Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Lidocaine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Lidocaine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Lidocaine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lidocaine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lidocaine Injection, Product Type & Application
- 3.8 Global Manufacturers of Lidocaine Injection, Established Date
- 3.9 Global Lidocaine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actiza Pharmaceutical
- 4.1.1 Actiza Pharmaceutical Company Information
- 4.1.2 Actiza Pharmaceutical Business Overview
- 4.1.3 Actiza Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actiza Pharmaceutical Lidocaine Injection Product Portfolio
- 4.1.5 Actiza Pharmaceutical Recent Developments
- 4.2 AdvaCare Pharma
- 4.2.1 AdvaCare Pharma Company Information
- 4.2.2 AdvaCare Pharma Business Overview
- 4.2.3 AdvaCare Pharma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AdvaCare Pharma Lidocaine Injection Product Portfolio
- 4.2.5 AdvaCare Pharma Recent Developments
- 4.3 Amphastar
- 4.3.1 Amphastar Company Information
- 4.3.2 Amphastar Business Overview
- 4.3.3 Amphastar Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amphastar Lidocaine Injection Product Portfolio
- 4.3.5 Amphastar Recent Developments
- 4.4 AuroMedics
- 4.4.1 AuroMedics Company Information
- 4.4.2 AuroMedics Business Overview
- 4.4.3 AuroMedics Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AuroMedics Lidocaine Injection Product Portfolio
- 4.4.5 AuroMedics Recent Developments
- 4.5 Hameln Pharmaceuticals
- 4.5.1 Hameln Pharmaceuticals Company Information
- 4.5.2 Hameln Pharmaceuticals Business Overview
- 4.5.3 Hameln Pharmaceuticals Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hameln Pharmaceuticals Lidocaine Injection Product Portfolio
- 4.5.5 Hameln Pharmaceuticals Recent Developments
- 4.6 Hikma
- 4.6.1 Hikma Company Information
- 4.6.2 Hikma Business Overview
- 4.6.3 Hikma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Hikma Lidocaine Injection Product Portfolio
- 4.6.5 Hikma Recent Developments
- 4.7 Livealth Biopharma
- 4.7.1 Livealth Biopharma Company Information
- 4.7.2 Livealth Biopharma Business Overview
- 4.7.3 Livealth Biopharma Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Livealth Biopharma Lidocaine Injection Product Portfolio
- 4.7.5 Livealth Biopharma Recent Developments
- 4.8 Fresenius Kabi
- 4.8.1 Fresenius Kabi Company Information
- 4.8.2 Fresenius Kabi Business Overview
- 4.8.3 Fresenius Kabi Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Fresenius Kabi Lidocaine Injection Product Portfolio
- 4.8.5 Fresenius Kabi Recent Developments
- 4.9 Hainan Tianhuang Pharmacy
- 4.9.1 Hainan Tianhuang Pharmacy Company Information
- 4.9.2 Hainan Tianhuang Pharmacy Business Overview
- 4.9.3 Hainan Tianhuang Pharmacy Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hainan Tianhuang Pharmacy Lidocaine Injection Product Portfolio
- 4.9.5 Hainan Tianhuang Pharmacy Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Lidocaine Injection Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 JumpCan
- 4.11.1 JumpCan Company Information
- 4.11.2 JumpCan Business Overview
- 4.11.3 JumpCan Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 JumpCan Lidocaine Injection Product Portfolio
- 4.11.5 JumpCan Recent Developments
- 4.12 LongerPharm Group
- 4.12.1 LongerPharm Group Company Information
- 4.12.2 LongerPharm Group Business Overview
- 4.12.3 LongerPharm Group Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 LongerPharm Group Lidocaine Injection Product Portfolio
- 4.12.5 LongerPharm Group Recent Developments
- 4.13 Yabao Pharmaceutical
- 4.13.1 Yabao Pharmaceutical Company Information
- 4.13.2 Yabao Pharmaceutical Business Overview
- 4.13.3 Yabao Pharmaceutical Lidocaine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Yabao Pharmaceutical Lidocaine Injection Product Portfolio
- 4.13.5 Yabao Pharmaceutical Recent Developments
5 Global Lidocaine Injection Market Scenario by Region
- 5.1 Global Lidocaine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lidocaine Injection Sales by Region: 2021-2032
- 5.2.1 Global Lidocaine Injection Sales by Region: 2021-2026
- 5.2.2 Global Lidocaine Injection Sales by Region: 2027-2032
- 5.3 Global Lidocaine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Lidocaine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Lidocaine Injection Revenue by Region: 2027-2032
- 5.4 North America Lidocaine Injection Market Facts & Figures by Country
- 5.4.1 North America Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lidocaine Injection Sales by Country (2021-2032)
- 5.4.3 North America Lidocaine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lidocaine Injection Market Facts & Figures by Country
- 5.5.1 Europe Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lidocaine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Lidocaine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Lidocaine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lidocaine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lidocaine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lidocaine Injection Market Facts & Figures by Country
- 5.7.1 South America Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lidocaine Injection Sales by Country (2021-2032)
- 5.7.3 South America Lidocaine Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Lidocaine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lidocaine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lidocaine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lidocaine Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lidocaine Injection Sales by Type (2021-2032)
- 6.1.1 Global Lidocaine Injection Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Lidocaine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Lidocaine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Lidocaine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lidocaine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Lidocaine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lidocaine Injection Sales by Application (2021-2032)
- 7.1.1 Global Lidocaine Injection Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Lidocaine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Lidocaine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Lidocaine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lidocaine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Lidocaine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lidocaine Injection Value Chain Analysis
- 8.1.1 Lidocaine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lidocaine Injection Production Mode & Process
- 8.2 Lidocaine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lidocaine Injection Distributors
- 8.2.3 Lidocaine Injection Customers
9 Global Lidocaine Injection Analyzing Market Dynamics
- 9.1 Lidocaine Injection Industry Trends
- 9.2 Lidocaine Injection Industry Drivers
- 9.3 Lidocaine Injection Industry Opportunities and Challenges
- 9.4 Lidocaine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst